Skip to main content
. 2021 Jan 25;2020:393–401.

Table 1. Breakdown of the study populations by site.

Site ADRD At-risk population prevalence
Site 1 128 3,292 5.34%
Site 2 10 983 1.02%
Site 3 711 12,181 5.84%
All sources 849 16,456 5.16%